C.R. Bard Inc (BCR: NYSE)
$215.53 1.65 | 0.77%
05/05/16 - 04:02 PM ET
|REVENUE (Trailing 12 Quarters)|
|EARNINGS PER SHARE (Trailing 12 Quarters)|
|DIVIDENDS (Trailing 12 Quarters)|
Portfolios with BCR
- Portfolio NameUser Type
- ProRenaissance Technologies
- ProDonald Yacktman - Yacktman ...
- ProAl Gore - Generation Invest...
- ContributorTechnical Setups for the We...
- ContributorStocks Fund Managers Love A...
- ContributorDividend Stocks for the Wee...
- Contributor18 Dividend Stocks That Wil...
- Contributor10 Best 'Dividend Aristocra...
- Contributor12 Stocks for a Diverse Mon...
- UserLes's Picks
Latest BCR Headlines from TheStreet
- 5 Overvalued Healthcare Stocks to Sell Now 09.29.15 | 08:09 am
- Jim Cramer Says Buy Celgene at $113 or Below, Skyworks in the $70s 09.01.15 | 12:09 pm
- Analysts' Actions -- New Ratings on Abercrombie & Fitch, SolarCity and Others 08.27.15 | 08:08 am
- 50 Stocks to Watch for Good Plays: Jim Cramer's Best Blogs 08.14.15 | 09:08 pm
- New Lifetime High Today: CR Bard (BCR) 07.24.15 | 09:07 am
- Bard (C.R.) (BCR) Earnings Report: Q2 2015 Conference Call Transcript 07.24.15 | 06:07 am
- C.R. Bard Becomes #136 Most Shorted S&P 500 Component, Replacing Waters 07.15.15 | 09:07 am
- Trade-Ideas: CR Bard (BCR) Is Today's Strong And Under The Radar Stock 07.09.15 | 09:07 am
- C.R. Bard Becomes #154 Most Shorted S&P 500 Component, Replacing Franklin Resources 05.29.15 | 04:05 pm
- CR Bard (BCR) Earnings Report: Q1 2015 Conference Call Transcript 04.24.15 | 09:04 am
Press Releases for BCR
- CMS Approves Add-on Payment For Lutonix® Drug-Coated Balloon For Inpatient Use - Business Wire 08.03.15 | 07:08 am
- Bard Announces Second Quarter Results - Business Wire 07.23.15 | 04:07 pm
- Bard To Host Earnings Conference Call On July 23, 2015 - Business Wire 07.01.15 | 12:07 pm
- The New England Journal Of Medicine Publishes LEVANT 2 Results For The Lutonix® Drug Coated Balloon, Showing Superior Efficacy Compared To Standard PTA - Business Wire 06.25.15 | 07:06 am
- Bard Announces $500 Million Share Repurchase Authorization - Business Wire 06.10.15 | 04:06 pm
- Bard Increases Quarterly Dividend - Business Wire 06.10.15 | 04:06 pm
- CMS Further Improves Reimbursement For Lutonix DCB For Outpatient Use - Business Wire 06.09.15 | 11:06 am
- Bard To Present At Jefferies Healthcare Conference - Business Wire 05.26.15 | 10:05 am
- Bard To Present At The Bank Of America Merrill Lynch Healthcare Conference - Business Wire 05.05.15 | 10:05 am
- Bard Announces First Quarter Results - Business Wire 04.23.15 | 04:04 pm
Partner Headlines for BCR
- C.R. Bard price target raised to $224 from $205 at Leerink - The Fly 04.28.16 | 08:04 am
- C.R. Bard, Inc. (BCR) Ex-Dividend Date Scheduled for April 28, 2016 - NASDAQ 04.27.16 | 01:04 pm
- C.R. Bard initiated with a Neutral at Nomura - The Fly 03.17.16 | 05:03 am
- C.R. Bard (BCR) Beats Q4 Earnings, FY16 View Positive - Zacks 01.29.16 | 09:01 am
- C.R. Bard, Inc. (BCR) Ex-Dividend Date Scheduled for January 21, 2016 - NASDAQ 01.20.16 | 02:01 pm
- CryoLife Agrees to Acquire On-X Life for $130 Million - Zacks 12.23.15 | 09:12 am
- C.R. Bard acquisition positive, says JMP Securities - The Fly 11.23.15 | 08:11 am
- C.R. Bard initiated with a Buy at Citi - The Fly 11.12.15 | 06:11 am
- C.R. Bard, Inc. (BCR) Ex-Dividend Date Scheduled for October 22, 2015 - NASDAQ 10.21.15 | 01:10 pm
- C.R. Bard price target raised to $220 from $200 at JMP Securities - The Fly 09.10.15 | 07:09 am